PMDA drug package insert
アズレイうがい液4%
PMDA Prescription drug · 株式会社ジーシー昭和薬品 · package insert Feb 19, 2024
Key facts
| Brand names | アズレイうがい液4% |
|---|---|
| Nonproprietary names | アズレンスルホン酸ナトリウム水和物 |
| Companies | 製造販売元／株式会社ジーシー昭和薬品 |
| Product type | Prescription drug |
| Therapeutic category | アズレン含嗽液 |
| Therapeutic category codes | 87226 |
| YJ codes | 2260700F1056 |
| Approval numbers | 21700AMZ00479000 |
| Package insert edition | 第1版 |
| Package insert date | Feb 19, 2024 |
| PMDA document key | 671610_2260700F1056_2 |
| PMDA company code | 671610 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: